Brief: Grifols Receives FDA Approval For Its Malaria Blood Screening Assay
16/04/2026 13:23
April 16 (Reuters) - Grifols SA GRLS.MC: RECEIVES FDA APPROVAL FOR ITS MALARIA BLOOD SCREENING ASSAY Source text Further company coverage: GRLS.MC (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))
Recent news on Grifols
See all newsSpanish stocks - Factors to watch on Nov 3
Brief: Grifols Approves Interim Dividend Of €0.15/Shr Payable On Dec 4
Brief: Grifols Q3 Group Profit €162 Mln
Refile: Grifols says Canada plasma license suspension has no impact on ongoing operations
Brief: Health Canada Suspends Licence Of Grifols Site In Winnipeg - Globe And Mail